The primary role of the immune system is to discriminate between self and non-self. Specific recognition of antigen is dependent on the ability of lymphocytes to generate a wide array of clonal receptors. The variable regions of the T cell antigen receptors (TCR) are encoded by separated gene segments which undergo rearrangement and joining during T cell development. The major source of T cell receptor diversity resides at the site of gene segment joining and random addition of junctional nucleotides. This latter process appears coincidentally with terminal deoxynucleotidyl transferase (TdT) activity, although the contribution of TdT has not yet been formally proven in vivo. Control of the T cell receptor repertoire is essential to the prevention of autoimmune disease. Although alpha beta T cells are subjected to selection in the thymus; the site of gamma delta T cell selection is still a subject of intense investigation. During murine fetal life, initial waves of gamma delta T cell precursors express limited junctional diversity and a selected germline repertoire. Adult dendritic epidermal cells (DEC) bear a similar germline TCR repertoire and also express little junctional diversity. In this study, we propose to create transgenic mice which express TdT at high levels during fetal life. Through sequence analysis of gamma delta TCR rearrangements in fetal thymocytes, we will test the influence of inappropriate TdT activity on the generation of N region diversity in vivo. Through examination of adult DEC cells, we will determine whether or not the virtually monomorphic T cell receptors found in this T cell subset is the result of positive selection, or simply due to their derivation from fetal thymocytes which similarly fail to exhibit junctional diversity. These studies should not only shed light on the mechanisms which control diversification of the T cell antigen receptor repertoire, but in the future will allow us to test the effect of abnormal diversification of the repertoire on the development of gamma beta T cells and in other mouse models of autoimmune disease.

Project Start
Project End
Budget Start
Budget End
Support Year
15
Fiscal Year
1992
Total Cost
Indirect Cost
Name
University of Alabama Birmingham
Department
Type
DUNS #
004514360
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Wu, Jianming; Xie, Fenglong; Qian, Kun et al. (2011) FAS mRNA editing in Human Systemic Lupus Erythematosus. Hum Mutat 32:1268-77
Wang, Feng; Ezell, Scharri J; Zhang, Yong et al. (2010) FBA-TPQ, a novel marine-derived compound as experimental therapy for prostate cancer. Invest New Drugs 28:234-41
Wang, Wei; Rayburn, Elizabeth R; Velu, Sadanandan E et al. (2009) In vitro and in vivo anticancer activity of novel synthetic makaluvamine analogues. Clin Cancer Res 15:3511-8
Wang, Wei; Rayburn, Elizabeth R; Zhao, Yuqing et al. (2009) Novel ginsenosides 25-OH-PPD and 25-OCH3-PPD as experimental therapy for pancreatic cancer: anticancer activity and mechanisms of action. Cancer Lett 278:241-248
Wang, Wei; Rayburn, Elizabeth R; Hang, Jie et al. (2009) Anti-lung cancer effects of novel ginsenoside 25-OCH(3)-PPD. Lung Cancer 65:306-11
Wang, Wei; Rayburn, Elizabeth R; Hao, Miao et al. (2008) Experimental therapy of prostate cancer with novel natural product anti-cancer ginsenosides. Prostate 68:809-19
Annis, Douglas S; Gunderson, Kristin A; Mosher, Deane F (2007) Immunochemical analysis of the structure of the signature domains of thrombospondin-1 and thrombospondin-2 in low calcium concentrations. J Biol Chem 282:27067-75
Rayburn, Elizabeth R; Wang, Wei; Zhang, Ruiwen et al. (2007) Experimental therapy for colon cancer: anti-cancer effects of TLR9 agonism, combination with other therapeutic modalities, and dependence upon p53. Int J Oncol 30:1511-9
Wang, Hui; Rayburn, Elizabeth R; Wang, Wei et al. (2006) Immunomodulatory oligonucleotides as novel therapy for breast cancer: pharmacokinetics, in vitro and in vivo anticancer activity, and potentiation of antibody therapy. Mol Cancer Ther 5:2106-14
Annis, D S; Murphy-Ullrich, J E; Mosher, D F (2006) Function-blocking antithrombospondin-1 monoclonal antibodies. J Thromb Haemost 4:459-68

Showing the most recent 10 out of 145 publications